Type 1 interferon-(alpha, beta, omega)-producing cells (IPC/pDC), or plasmacytoid dendritic cell precursors (pDC) represent 0.2-0.8 of peripheral blood mononuclear cells in both humans and mice. IPC/pDC display plasmacell morphology, have the capacity to produce a large amount of type 1 IFN following viral stimulation, and are able to differentiate into professional antigen presenting dendritic cells (called plasmacytoid DCs). Studies of HIV-infected human subjects and of a murine model of viral infection demonstrated that IPC/pDC are the key effectors in anti-viral innate immunity. In addition, recent studies have shown that patients suffering from systemic lupus erythematosis (SLE) have an elevated level of serum IFN-a, resulting from constitutively activation of IPC/pDC by DNA and anti-DNA antibody complexes in SLE patients, and contribute to the pathological processes of SLE. Therefore understanding the developmental regulation of IPC/pDCs may have important implication in controlling viral infections and autoimmune diseases. We have previously shown that FLT3-L represents a key differentiation factor for IPC/pDC development from hematopoietic stem cells in humans and mice, and developed the in vitro culture system to generate human and mouse IPC/pDC. However, the developmental steps of IPC/pDC from early hematopoietic stem cells, and its lineage relationship to lymphoid and myeloid lineages are poorly defined. The molecular regulation of IPC/Pdc development by other growth factors and signaling pathways are largely undefined. In this grant application, we have three aims: 1) To define the developmental steps and lineage origin of human IPCs;2) to define the developmental steps and lineage origin of mouse IPCs;and 3) to investigate the molecular mechanisms which regulate IPC development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI059718-05
Application #
7564698
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Lapham, Cheryl K
Project Start
2005-01-01
Project End
2010-12-31
Budget Start
2009-01-01
Budget End
2010-12-31
Support Year
5
Fiscal Year
2009
Total Cost
$351,137
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Li, Haiyan S; Gelbard, Alexander; Martinez, Gustavo J et al. (2011) Cell-intrinsic role for IFN-*-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Blood 118:3879-89
Watowich, Stephanie S; Liu, Yong-Jun (2010) Mechanisms regulating dendritic cell specification and development. Immunol Rev 238:76-92
Cao, Wei; Bover, Laura; Cho, Minkwon et al. (2009) Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med 206:1603-14
Esashi, Eiji; Wang, Yui-Hsi; Perng, Olivia et al. (2008) The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28:509-20